Humana Inc. $HUM Stake Increased by Pacer Advisors Inc.

Pacer Advisors Inc. increased its holdings in shares of Humana Inc. (NYSE:HUM) by 42.3% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 14,793 shares of the insurance provider’s stock after buying an additional 4,401 shares during the quarter. Pacer Advisors Inc.’s holdings in Humana were worth $3,849,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also recently bought and sold shares of the company. Swedbank AB boosted its position in Humana by 4.9% during the 3rd quarter. Swedbank AB now owns 105,269 shares of the insurance provider’s stock worth $27,388,000 after acquiring an additional 4,872 shares during the period. IFM Investors Pty Ltd boosted its holdings in shares of Humana by 0.4% during the third quarter. IFM Investors Pty Ltd now owns 23,826 shares of the insurance provider’s stock worth $6,074,000 after purchasing an additional 97 shares during the period. Farther Finance Advisors LLC boosted its holdings in shares of Humana by 8.3% during the third quarter. Farther Finance Advisors LLC now owns 1,955 shares of the insurance provider’s stock worth $509,000 after purchasing an additional 149 shares during the period. OFI Invest Asset Management grew its position in Humana by 37.4% during the third quarter. OFI Invest Asset Management now owns 536 shares of the insurance provider’s stock valued at $139,000 after purchasing an additional 146 shares in the last quarter. Finally, Red Door Wealth Management LLC acquired a new position in Humana in the 3rd quarter valued at approximately $201,000. 92.38% of the stock is owned by institutional investors and hedge funds.

Humana Stock Down 0.1%

HUM opened at $258.50 on Tuesday. The firm has a market cap of $31.09 billion, a P/E ratio of 24.23, a price-to-earnings-growth ratio of 1.51 and a beta of 0.46. The company has a debt-to-equity ratio of 0.68, a quick ratio of 2.02 and a current ratio of 2.02. The business has a 50 day moving average price of $258.07 and a 200 day moving average price of $260.74. Humana Inc. has a twelve month low of $206.87 and a twelve month high of $315.35.

Humana (NYSE:HUM) last released its quarterly earnings results on Wednesday, November 5th. The insurance provider reported $3.24 EPS for the quarter, beating analysts’ consensus estimates of $2.95 by $0.29. Humana had a net margin of 1.02% and a return on equity of 12.86%. The company had revenue of $32.65 billion for the quarter, compared to analyst estimates of $31.99 billion. During the same quarter last year, the firm posted $4.16 earnings per share. The company’s quarterly revenue was up 11.1% compared to the same quarter last year. Research analysts forecast that Humana Inc. will post 16.47 EPS for the current year.

Humana Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, January 30th. Shareholders of record on Friday, December 26th will be given a dividend of $0.885 per share. The ex-dividend date of this dividend is Friday, December 26th. This represents a $3.54 dividend on an annualized basis and a yield of 1.4%. Humana’s payout ratio is currently 33.18%.

Wall Street Analyst Weigh In

A number of equities research analysts have issued reports on HUM shares. Wells Fargo & Company lifted their target price on shares of Humana from $344.00 to $347.00 and gave the company an “overweight” rating in a research note on Tuesday, October 7th. Barclays reduced their price objective on Humana from $245.00 to $234.00 and set an “equal weight” rating for the company in a research report on Tuesday, November 25th. Morgan Stanley reaffirmed an “underperform” rating on shares of Humana in a research note on Thursday, December 18th. Jefferies Financial Group upgraded Humana from a “hold” rating to a “buy” rating and lifted their price target for the company from $253.00 to $313.00 in a report on Friday, December 5th. Finally, KeyCorp restated a “sector weight” rating on shares of Humana in a report on Friday, December 12th. Nine investment analysts have rated the stock with a Buy rating, nine have given a Hold rating and three have issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus target price of $294.32.

Humana Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.